Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Friday, November 19, 2021
Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to ...
read more
Wednesday, November 17, 2021
Endo International plc announced that its subsidiary, Par Sterile Products, LLC (Par Sterile), has entered into a cooperative agreement to expand its sterile fill-finish manufacturing production ...
read more
Wednesday, November 17, 2021
Twist Bioscience Corporation has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology company to develop and commercialize an antibody, discovered and optimized by ...
read more
Tuesday, November 16, 2021
Health Canada has authorized the use of the Moderna Spikevax COVID-19 vaccine as a booster shot. A COVID-19 booster shot is an extra dose of the vaccine given after completion of the primary vaccine ...
read more
Monday, November 15, 2021
Regeneron Pharmaceuticals announced that the European Commission (EC) has approved the casirivimab and imdevimab antibody cocktail, known as REGEN-COV® in the U.S. and Ronapreve™ in the European Union...
read more
Wednesday, November 03, 2021
AbCellera announced an additional purchase by the U.S. government from Eli Lilly and Company (Lilly) for bamlanivimab with etesevimab for administration together. This neutralizing antibody therapy is...
read more
Monday, November 01, 2021
Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion of its rolling submission to ...
read more
Monday, November 01, 2021
Novavax, a biotech company dedicated to developing and commercializing next-gen vaccines, and Serum Institute of India, the world's highest volume vaccine manufacturer, announced that the National ...
read more
Monday, November 01, 2021
Pfizer and BioNTech announced that the FDA has authorized for emergency use the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of
read more
Pfizer and BioNTech announced that the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 17 to 0, with 1 abstention, to recommend that the FDA grant Emergency Use ...
read more
Pfizer and BioNTech announced that the U.S. government has purchased 50 million more doses of the companies’ COVID-19 vaccine. The U.S. will receive these additional doses to continue to support ...
read more
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) ...
read more
Thursday, October 28, 2021
Throughout the pandemic, the Government of Canada has worked closely with vaccine manufacturers to negotiate the delivery of vaccines to Canada as quickly as possible.
On October 18, 2021, Pfizer ...
read more
Thursday, October 28, 2021
Johnson & Johnson announced that the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), has recommended its COVID-19 vaccine as a booster for ...
read more
Thursday, October 28, 2021
Pfizer and BioNTech announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more ...
read more